Target intelligence / Profile preview

Vav guanine nucleotide exchange factor 1 (VAV1)

Target
VAV1
Molecular classification
Enzyme, Other
01

Overview

Vav guanine nucleotide exchange factor 1 (VAV1) is a critical intracellular signal transduction protein predominantly expressed in hematopoietic cells, where it acts as a key regulator of T-cell and B-cell receptor signaling. Upon activation by tyrosine phosphorylation, VAV1 functions as a guanine nucleotide exchange factor (GEF) for Rho-family GTPases, primarily Rac1, thereby driving cytoskeletal remodeling, immunological synapse formation, and the activation of downstream transcription factors like NFAT and NF-kB. Because of its central role in lymphocyte activation and cytokine production, dysregulation of VAV1 is heavily implicated in autoimmune and chronic inflammatory diseases, as well as certain hematological malignancies. Historically considered 'undruggable' due to the lack of a classical small-molecule binding pocket, VAV1 has recently emerged as a high-value therapeutic target through the development of targeted protein degradation (TPD) modalities. Novel clinical-stage molecular glue degraders, such as MRT-6160 and EVO570, selectively recruit VAV1 to the cereblon (CRBN) E3 ubiquitin ligase complex, inducing its ubiquitination and subsequent proteasomal degradation to quiet aberrant immune responses.

Other names
Proto-oncogene vavp95vavVAVVav-1Vav guanine nucleotide exchange factor
02

Mechanism of action

Targeted protein degradation via molecular glue-mediated recruitment to the cereblon (CRBN) E3 ubiquitin ligase, leading to ubiquitination and proteasomal degradation.

03

Biological functions

Signal transductionImmune responseCell proliferationCell cycleOther
04

Disease associations

InflammationCancerOther
05

Safety considerations

ImmunosuppressionIncreased risk of infectionOff-target degradation of other neosubstratesImpaired T-cell and B-cell development
06

Interacting drugs

MRT-6160 (DDY391)

3 more in the full profile.

07

Biomarkers

VAV1 protein levelsT-cell activation markersB-cell activation markersPro-inflammatory cytokinesCalprotectin

Beyond the preview

Go deeper on Vav guanine nucleotide exchange factor 1 (VAV1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vav guanine nucleotide exchange factor 1 (VAV1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call